Cell-free DNA copy number variations in plasma from colorectal cancer patients

Molecular Oncology

Volumn 11, Issue 8, 2017, Pages 1099-1111

  Li, Jian ^a,b   Dittmar, Rachel L ^b   Xia, Shu ^b,c   Zhang, Huijuan ^b,d   Du, Meijun ^b   Huang, Chiang Ching ^e   Druliner, Brooke R ^f   Boardman, Lisa ^f   Wang, Liang ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d Office of Community Medicine and Preventive Health Care   (China)

^e UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^f MAYO CLINIC   (United States)

Author keywords

cell free DNA; colon cancer; copy number variation; next generation sequencing; survival

Indexed keywords

B RAF KINASE; BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE 8; EVEROLIMUS; FLUOROURACIL; IRS2 PROTEIN; JANUS KINASE; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE P60; PROTEIN P53; STAT PROTEIN; UNCLASSIFIED DRUG; VATALANIB; CIRCULATING TUMOR DNA;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CELL CYCLE; CELL FREE SYSTEM; CHROMOSOME LOSS; COHORT ANALYSIS; COLORECTAL CANCER; COLORECTAL POLYP; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA CONTENT; DNA REPAIR; FEMALE; GENE AMPLIFICATION; GENE LOCUS; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; WHOLE GENOME SEQUENCING; WNT SIGNALING PATHWAY; BLOOD; CLINICAL TRIAL; COLORECTAL TUMOR; GENETICS; HUMAN CHROMOSOME; MIDDLE AGED; VERY ELDERLY; WNT SIGNALING;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN; CIRCULATING TUMOR DNA; COLORECTAL NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE AMPLIFICATION; HUMANS; MALE; MIDDLE AGED; WNT SIGNALING PATHWAY;

EID: 85026647192     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1002/1878-0261.12077     Document Type: Article

References (32)

1. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM et al. (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6, 224ra224.
2. Bretthauer M (2011) Colorectal cancer screening. J Intern Med 270, 87–98.
3. Carethers JM and Jung BH (2015) Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149, 1177–1190. e1173
4. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MA, van Criekinge W, Thas O, Matthai A, Cuesta MA et al. (2009) Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 58, 79–89.
5. Chao M and Gibbs P (2009) Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer. J Clin Oncol 27, e279–e280. author reply e281.
6. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC and Lothe RA (2006) The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosom Cancer 45, 31–41.
7. Diskin SJ, Li M, Hou C, Yang S, Glessner J, Hakonarson H, Bucan M, Maris JM and Wang K (2008) Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res 36, e126.
8. Eldai H, Periyasamy S, Al Qarni S, Al Rodayyan M, Muhammed Mustafa S, Deeb A, Al Sheikh E, Afzal M, Johani M, Yousef Z et al. (2013) Novel genes associated with colorectal cancer are revealed by high resolution cytogenetic analysis in a patient specific manner. PLoS ONE 8, e76251.
9. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–E386.
10. Forones NM and Tanaka M (1999) CEA and CA 19-9 as prognostic indexes in colorectal cancer. Hepatogastroenterology 46, 905–908.
11. Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Lee KH, Won JK, Kim TY, Oh DY, Im SA et al. (2013) Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing. PLoS ONE 8, e64271.
12. Heitzer E, Ulz P, Geigl JB and Speicher MR (2016) Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies. Mol Oncol 10, 494–502.
13. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W et al. (2002) Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123, 1109–1119.
14. Hudecova I (2015) Digital PCR analysis of circulating nucleic acids. Clin Biochem 48, 948–956.
15. Issa JP (2008) Colon cancer: it's CIN or CIMP. Clin Cancer Res 14, 5939–5940.
16. Knosel T, Schluns K, Stein U, Schwabe H, Schlag PM, Dietel M and Petersen I (2004) Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia 6, 23–28.
17. Krishnamurthy N, Spencer E, Torkamani A and Nicholson L (2017) Liquid biopsies for cancer: coming to a patient near you. J Clin Med 6, 3.
18. Lee KS, Kwak Y, Nam KH, Kim DW, Kang SB, Choe G, Kim WH and Lee HS (2015) c-MYC copy-number gain is an independent prognostic factor in patients with colorectal cancer. PLoS ONE 10, e0139727.
19. Mekenkamp LJ, Tol J, Dijkstra JR, de Krijger I, Vink-Borger ME, van Vliet S, Teerenstra S, Kamping E, Verwiel E, Koopman M et al. (2012) Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients. BMC Cancer 12, 292.
20. Muller MF, Ibrahim AE and Arends MJ (2016) Molecular pathological classification of colorectal cancer. Virchows Arch 469, 125–134.
21. Muzny DM, Bainbridge MN, Chang K, Dinh HH and Drummond JA (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337.
22. Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C et al. (2016) Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol 34, 547–555.
23. Ogunbiyi OA, Goodfellow PJ, Gagliardi G, Swanson PE, Birnbaum EH, Fleshman JW, Kodner IJ and Moley JF (1997) Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology 113, 761–766.
24. Postma C, Terwischa S, Hermsen MA, van der Sijp JR and Meijer GA (2007) Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer. Cell Oncol 29, 73–75.
25. Stahlberg A, Krzyzanowski PM, Jackson JB, Egyud M, Stein L and Godfrey TE (2016) Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing. Nucleic Acids Res 44, e105.
26. Storey JD and Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100, 9440–9445.
27. Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M et al. (2016) Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med 8, 346ra392.
28. Vukobrat-Bijedic Z, Husic-Selimovic A, Sofic A, Bijedic N, Bjelogrlic I, Gogov B and Mehmedovic A (2013) Cancer antigens (CEA and CA 19-9) as markers of advanced stage of colorectal carcinoma. Med Arch 67, 397–401.
29. Wang H, Liang L, Fang JY and Xu J (2016) Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers. Oncogene 35, 2011–2019.
30. Xia S, Huang CC, Le M, Dittmar R, Du M, Yuan T, Guo Y, Wang Y, Wang X, Tsai S et al. (2015a) Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls. Lung Cancer 90, 78–84.
31. Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR et al. (2015b) Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer. Oncotarget 6, 16411–16421.
32. Zweig MH and Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39, 561–577.